Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    HT Staff

    News

    Pain problems prevalent in adults with hemophilia

    Author:
    HT Staff
    Publish date: July 2, 2015

    TORONTO—A survey of adult hemophilia patients suggests there is room for improvement in assessing and managing disease-related pain. Roughly 85%...

    • Read More

    News

    Mutations linked to response, survival in aplastic anemia

    Author:
    HT Staff
    Publish date: July 2, 2015

    Photo by Graham Colm Scientists have identified genetic mutations that appear to be associated with treatment outcomes in patients with aplastic...

    • Read More

    News

    Radiation increases risk of death from CML, other leukemias

    Author:
    HT Staff
    Publish date: July 1, 2015

    power plant in Germany Protracted exposure to ionizing radiation, even at low doses, can increase a person’s risk of dying from certain leukemias...

    • Read More

    News

    Intervention reduces CLABSIs in pediatric patients

    Author:
    HT Staff
    Publish date: July 1, 2015

    Staphylococcus infection Photo by Bill Branson NASHVILLE—A single-center study has shown that incorporating antimicrobial cloths into an...

    • Read More

    News

    Drug can produce durable responses in rel/ref PTCL

    Author:
    HT Staff
    Publish date: July 1, 2015

    anaplastic large cell lymphoma The histone deacetylase inhibitor belinostat can produce durable responses in patients with relapsed/refractory...

    • Read More

    News

    Extended-interval dosing appears safe, effective

    Author:
    HT Staff
    Publish date: July 1, 2015

    Photo courtesy of Biogen TORONTO—Full results of a phase 3 study support extended-interval dosing with a recombinant factor IX Fc fusion protein...

    • Read More

    News

    Anticoagulant antidote effective in healthy volunteers

    Author:
    HT Staff
    Publish date: June 30, 2015

    TORONTO—An antidote to factor Xa inhibitors can safely reverse the anticoagulant effect of apixaban in healthy volunteers, results of the ANNEXA-A...

    • Read More

    News

    Cord milking better than delayed clamping for some preterm infants

    Author:
    HT Staff
    Publish date: June 30, 2015

    Photo courtesy of Meutia Chaerani & Indradi Soemardjan Umbilical cord milking may be more beneficial than delayed cord clamping for preterm...

    • Read More

    News

    Long-term data support use of FVIII treatment

    Author:
    HT Staff
    Publish date: June 29, 2015

    TORONTO—The antihemophilic factor turoctocog alfa is safe and effective long-term, according to interim data from the phase 3 guardian 2 trial....

    • Read More

    News

    Insecticide can cause NHL, experts say

    Author:
    HT Staff
    Publish date: June 29, 2015

    Photo by John Messina The insecticide gamma-hexachlorocyclohexane (lindane) is carcinogenic, according to experts from the International Agency...

    • Read More

    News

    EC approves edoxaban for patients with VTE, NVAF

    Author:
    HT Staff
    Publish date: June 28, 2015

    Image by Andre E.X.

    • Read More

    News

    CHMP recommends panobinostat for MM

    Author:
    HT Staff
    Publish date: June 27, 2015

    Photo courtesy of the CDC The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) is recommending regulatory...

    • Read More

    News

    Approach could build bridge to HSCT in T-PLL

    Author:
    HT Staff
    Publish date: June 26, 2015

    Photo by Chad McNeeley A treatment approach that combines epigenetics and immunotherapy could provide a bridge to transplant in patients with T-...

    • Read More

    News

    Bivalirudin provides no net benefit in PCI, doc says

    Author:
    HT Staff
    Publish date: June 26, 2015

    Photo by Frank C.

    • Read More

    News

    Nanobody can help treat acquired TTP

    Author:
    HT Staff
    Publish date: June 26, 2015

    Image by Erhabor Osaro TORONTO—Adding the anti-von Willebrand factor nanobody caplacizumab to standard therapy can provide clinical benefits for...

    • Read More

    Pages

    • « first
    • …
    • 170
    • 171
    • 172
    • 173
    • 174
    • 175
    • 176
    • 177
    • 178
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery